411 related articles for article (PubMed ID: 11032190)
1. Child vaccination, part 1: routine vaccines.
Zimmerman RK; Burns IT
J Fam Pract; 2000 Sep; 49(9 Suppl):S22-33. PubMed ID: 11032190
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
3. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
5. Combination vaccine use and vaccination quality in a managed care population.
Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
[TBL] [Abstract][Full Text] [Related]
6. [Vaccination of children in 1999].
Levy J
Rev Med Brux; 1999 Sep; 20(4):A317-20. PubMed ID: 10523915
[TBL] [Abstract][Full Text] [Related]
7. Routine vaccines across the life span, 2003.
Zimmerman RK; Middleton DB; Burns IT; Clover RD
J Fam Pract; 2003 Jan; 52(1 Suppl):S1-21. PubMed ID: 12556275
[TBL] [Abstract][Full Text] [Related]
8. The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program.
Smith PJ; Santoli JM; Chu SY; Ochoa DQ; Rodewald LE
Pediatrics; 2005 Jul; 116(1):130-9. PubMed ID: 15995043
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
10. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
[TBL] [Abstract][Full Text] [Related]
12. Child vaccination, part 2: childhood vaccination procedures.
Zimmerman RK; Burns IT
J Fam Pract; 2000 Sep; 49(9 Suppl):S34-9; quiz S40. PubMed ID: 11032191
[TBL] [Abstract][Full Text] [Related]
13. Improving child survival through immunisation.
Lamabadusuriya SP
Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
[TBL] [Abstract][Full Text] [Related]
14. National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Sep; 55(36):988-93. PubMed ID: 16971887
[TBL] [Abstract][Full Text] [Related]
15. Status report on the Childhood Immunization Initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(29):657-64. PubMed ID: 9237475
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
[TBL] [Abstract][Full Text] [Related]
18. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
20. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
